<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01104740</url>
  </required_header>
  <id_info>
    <org_study_id>10/B/01</org_study_id>
    <nct_id>NCT01104740</nct_id>
  </id_info>
  <brief_title>Dengue Seroprevalence Study in Blood Donors in the French West Indies</brief_title>
  <acronym>DengSeroprevAn</acronym>
  <official_title>Dengue Seroprevalence Study in Blood Donors in the French West Indies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Etablissement Français du Sang, Martinique</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MCM Vaccines B.V.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Clinique Antilles-Guyane</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Etablissement Français du Sang, Martinique</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dengue is an infectious disease most prevalent in the world. This disease is endemic in the
      Caribbean, with an increase in seasonal rains. Several outbreaks have been observed in recent
      years, in 2001, 2005 and 2007, during which further particularly virulent serotypes have
      emerged. The clinical expression of dengue fever is variable, ranging from no symptoms to a
      classical form with fever, and even of severe or lethal bleeding. With the possible existence
      of silent forms of the disease, there are no data identifying the current level of protection
      of the population in Martinique / Guadeloupe.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Principal objective:

           To estimate the prevalence of the specific antibodies of the dengue (IgG) in blood
           donors in the French West Indies.

        2. Secondary objective:

      To specify the serotypic specificity of the anti-dengue antibodies detected during the study.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>June 2010</start_date>
  <completion_date type="Anticipated">June 2010</completion_date>
  <primary_completion_date type="Anticipated">June 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence or not of dengue virus-specific immunoglobulin G antibodies</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Characterization of dengue virus serotype-specific IgG</measure>
    <time_frame>1 day</time_frame>
    <description>Characterization of dengue virus serotype-psecific IgG whendengue virus serotype-specific immunoglobulin G antibodies Test is positive</description>
  </secondary_outcome>
  <enrollment type="Anticipated">770</enrollment>
  <condition>Blood Donors</condition>
  <condition>Dengue</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biological sample collection</intervention_name>
    <description>Blood (serum) sample collection</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult, résidents in Martinique/ Guadeloupe (french west indies), aged 18 to 65 years coming
        to give their blood in one of the building or mobile collection facilities of the French
        Blood Establishment in French West Indies.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Eligible for blood donation following the French legislation,

          -  Resident in Martinique /Guadeloupe for at least one year

          -  Consent signed

        Exclusion Criteria:

          -  Not Eligible for blood donation following the French legislation,

          -  Not Resident in Martinique / Guadeloupe for at least one year

          -  Consent not signed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pascale RICHARD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>French Blood Establishment of Martinique</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Janick JEAN-MARIE, Master</last_name>
    <phone>592697</phone>
    <phone_ext>33596</phone_ext>
    <email>janick.jean-marie@chu-fortdefrance.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paul Mourlhou</last_name>
    <phone>592697</phone>
    <phone_ext>33596</phone_ext>
    <email>paul.mourlhou@chu-fortdefrance.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>French Blood Establishment of Guadeloupe</name>
      <address>
        <city>Pointe-à-Pitre</city>
        <zip>97171</zip>
        <country>Guadeloupe</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rémi Courbil, Ph.D</last_name>
      <phone>891555</phone>
      <phone_ext>33590</phone_ext>
      <email>remi.courbil@efs.sante.fr</email>
    </contact>
    <investigator>
      <last_name>Rémi Courbil, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>French Blood Establishment of Martinique</name>
      <address>
        <city>Fort-de-France</city>
        <zip>97264</zip>
        <country>Martinique</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pascale Richard, MD</last_name>
      <phone>757915</phone>
      <phone_ext>33596</phone_ext>
      <email>pascale.richard@efs.sante.fr</email>
    </contact>
    <investigator>
      <last_name>Pascale Richard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Guadeloupe</country>
    <country>Martinique</country>
  </location_countries>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2010</study_first_submitted>
  <study_first_submitted_qc>April 14, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2010</study_first_posted>
  <last_update_submitted>April 14, 2010</last_update_submitted>
  <last_update_submitted_qc>April 14, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 15, 2010</last_update_posted>
  <responsible_party>
    <name_title>RICHARD / Chef Executive Officer</name_title>
    <organization>Etablissement Français du sang de Martinique</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dengue</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

